Simply squeezing a lime into your water could be your ticket to dodging kidney stone pain

93% of patients in study had an antibody response against beta-amyloid

Patients starting SSRIs and lecanemab may warrant close monitoring

The immunotherapy drug, UB-311, developed by vaxxinity, has shown promising results in a Phase 2a clinical trial for the treatment of mild Alzheimer’s disease. The trial data, published in The Lancet’s eBioMedicine journal, indicates that UB-311 is safe and well tolerated and demonstrates a tendency to slow cognitive decline in patients with mild Alzheimer’s.

Finding the motivation to commute to a gym — not to mention working out when you get there — is a struggle. It’s time to take advantage of that little thing we do each time we run errands, park our cars, or take the stairs: walking.

UB-311 could offer multiple competitive advantages over licensed passive immunotherapies, including less frequent dosing, a more convenient mode of administration, improved accessibility and cost-effectiveness, and potentially lower rates of ARIA-E

With its depiction of the first atomic bomb explosion, the new film, "Oppenheimer," highlights the massive destructive power of these early nuclear weapons.

Radioactive particles from nuclear explosions are found in every corner of the world. Many people are worried about the bad effects of nuclear bombs.

Aqua jogging, or deep water running, is popular among injured runners since it’s a non-weight-bearing exercise that’s very similar to running. If athletes can’t go on their normal runs because of injuries, they can maintain their aerobic performance for several weeks with aqua jogging.

A daily serving of strawberries can improve cognitive function and heart health, a new study finds.

Research presented at Berry Health Benefits Symposium adds to growing body of evidence and highlights strawberry’s ‘food as medicine’ potential.

The drugs clear sticky plaques from the brain. But they are not for everyone, experts caution